We have developed a non-radioactive flow-cytometry assay to monitor and quantify the target-cell killing activities mediated by cytotoxic T lymphocytes (CTLs). This flow-cytometry CTL (FCC ...

Most flow cytometry assays are lab-developed tests (LDTs ... The standard CAR approach uses T cells, which are primed to fight infections. With the right gene editing, they can be engineered ...

Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...

The Cytometry and Cell Sorting Facility at Baylor College of Medicine provides training, instrumentation, technical expertise, and software for flow cytometric analysis and cell sorting. This site ...

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

The Flow Cytometry and Cell Separation Facility provides advanced cell sorting and cell analysis techniques including immunofluorescence detection of 18 colors, cell-cycle distribution, apoptosis ...

It covers a broad range of potential fluorophores and reagents, including Invitrogen labeling reagents, which allows the reader to make an informed decision when it comes to using flow cytometry in ...

The inherent diverse nature of differentiating cultures remains a challenge in stem cell research. Multicolor flow cytometry enables researchers to interrogate and quantify heterogeneous cell ...

Its intuitive touchscreen interface, easy-to-use software, and optimized “Mix-and-Read” assays combine to streamline and simplify flow cytometry analyses. The Muse Micro cell analyzer is built ...

It can precisely select single cells on a chip, carry out several single-cell assays, and export target ... of their membranes are organized by flow cytometry. What is the maximum number of ...

BrisSynBio has access to the equipment and expertise housed in the Flow Cytometry Facility. This comprises high speed digital benchtop cytometers for analysis and a state of the art Fluorescence ...

The following is a summary of “Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab,” published in the April 2025 issue of Journal of ...